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Retraction
The authors have retracted this article [1] as there was a
large overlap with a previously published article in Inter-
national Journal of Cancer [2]. Dr Lu ShihHsin,
although listed as an author, was not aware of the publi-
cation in Journal of Experimental & Clinical Cancer
Research and the grant reference number stated in the
acknowledgements was incorrectly applied to this article.
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